Health tech investment shows signs of recovery in 2024: SVB
Posted:
Funding in the first eight months of the year has already exceeded pre-pandemic levels, according to Silicon Valley Bank. But high valuations recorded in 2021 are still affecting the market.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us